Background. Group B streptococcus (GBS) is an important neonatal pathogen known to be associated with high morbidity and mortality. GBS is a well-known etiology of postpartum infection and recently is considered to be an emerging pathogen in adult patients causes severe sepsis and invasive infections. The aim of this study was to evaluate the rate of clindamycin and erythromycin resistance among GBS isolated from invasive and noninvasive clinical specimens over the past 13 years.
Methods. From 2004 to 2016, 134 invasive and 2,660 noninvasive, non-repetitive isolates were included in the study. The identification was done by using Vitek-2 and MIC was determined by E test.
Results. Among 134 invasive isolates, 124 were from blood, 94 from neonates and 30 from adults and 10 were from CSF. Clindamycin resistance rate for invasive GBS isolates were 5.3% in 2004-2006, 5.7% in 2011-2014, 23.7% in 2011-2014 and 43.5% in 2015-2016 with 23 (17.2%) overall resistant rate. The overall resistance rate to erythromycin among invasive strains was (29.4%, n = 42), however, it was 13.2% in 2004-2006, 25.7% in 2007-2010, 55.3% in 2011-2014 and 30.4% in 2015-2016 . Resistance pattern to clindamycin and erythromycin of noninvasive GBS isolates were as follow: (4. 4% and 8.1%) in 2004-2010 (21.6% and 33.8%) in 2010-2014 and (52.5% and 49.4%) in 2015-2016, respectively . All isolates were sensitive to penicillin, ampicillin, vancomycin and teicoplanin. However, 94.6% and 95.5% were highly resistant to gentamicin and tetracycline, respectively. Six serotypes were identified in invasive GBS isolates, III (28.8%) was the most prevalent, followed by V (20.7%), Ia and II (15.3%), Ib (8.1%), IV (7.2%), VII (0.9%) and 4 (3.6%) were NT. Serotype distribution of the noninvasive GBS was as follow: serotype V (31.4%), III (23.7%) and II (12.7%) were the predominant. A high level clindamycin and -erythromycin resistant invasive GBS strains with MIC > 256 µg/ml were (61.5% and20%) respectively.
Conclusion. Rate of GBS resistance to clindamycin and erythromycin are significantly increased over the study period. These findings should strongly support ACOG recommendations that clindamycin use for intrapartum prophylaxis to be restricted to penicillin allergic women and it necessitates that all GBS isolates to be tested for clindamycin.
Disclosures. All authors: No reported disclosures. Background. Surgical antimicrobial prophylaxis (SAP) is standard of care in clean surgery involving implants and in clean-contaminated surgical procedures. Timing of application of the antibiotic remains a debate: WHO recently extended the time prior to incision from 60 to 120 minutes, while CDC considers the availabdata insufficient to provide evidence-based guideline for timing. In addition, studies to date included different types of antibiotics with different T ½. Therefore, we prospectively followed 250'000 patients to further define the optimal timing for SAP Methods. The Swiss national center for infection prevention (www.swissnoso. ch) started surveillance for surgical site infection (SSI) in 2009. Currently, 172 institutions participate throughout Switzerland, with routine postdicharge surveillance (adherence >90%) and on-site quality audits by a physician or infection control practitioner. The data collection includes age, sex, type of surgery, timing of SAP in minutes prior to incision, BMI, ASA score, antimicrobial agent. Inclusion criteria for this study were: adult patients undergoing cardiac surgery, orthopedic or abdominal surgery, antimicrobial prophylaxis with cefuroxime only (+metronidazole for abdominal surgery) and pathogen identified in cases of SSI was cefuroxime-susceptible. Data were analyzed using a generalized additive model (GAM) to allow non-parametric fits with relaxed assumptions on the actual relationship between response and predictor Results. Of the 258'481 patients in the national SSI surveillance database 121'645 fulfilled the inclusion criteria (38% of patients did not require SAP, 18% had surgery with contaminated or dirty wounds, 2.7% were <18 years and data on timing and class of antibiotic were missing in 5.7%). The lowest risk of SSI was observed with application of SAP 0-30min prior incision, even after adjustment for age, sex, ASA score, type of surgery, BMI, and T1/2. ( 
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